Medadvisor Ltd
ASX:MDR

Watchlist Manager
Medadvisor Ltd Logo
Medadvisor Ltd
ASX:MDR
Watchlist
Price: 0.087 AUD 3.57%
Market Cap: 52m AUD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one MDR stock under the Base Case scenario is 0.272 AUD. Compared to the current market price of 0.087 AUD, Medadvisor Ltd is Undervalued by 68%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MDR Relative Value
Base Case
0.272 AUD
Undervaluation 68%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.5
P/S
P/S
Price to Sales
0.5
vs History
98
vs Industry
76
Median 3Y
1.1
Median 5Y
1.4
Industry
2.2
Forward
0.5
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-9
Median 5Y
-10.3
Industry
21.5
Forward
-1.9
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
42
Median 3Y
-9
Median 5Y
-12.7
Industry
13.7
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
35
Median 3Y
-7.6
Median 5Y
-14.9
Industry
20.1
More Details
0.9
P/B
P/B
Price to Book Value
0.9
vs History
98
vs Industry
62
Median 3Y
2.3
Median 5Y
2.6
Industry
2.1
More Details
0.5
EV/S
EV/S
Enterprise Value to Sales
0.5
vs History
98
vs Industry
76
Median 3Y
1.1
Median 5Y
1.3
Industry
2.3
Forward
0.6
More Details
0.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.8
vs History
98
vs Industry
81
Median 3Y
1.8
Median 5Y
2.4
Industry
4.8
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-11.8
Median 5Y
-9.5
Industry
11.5
Forward
-10.6
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-11.8
Median 5Y
-9.5
Industry
15.7
Forward
-6.6
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
44
Median 3Y
-9.2
Median 5Y
-11.5
Industry
13.6
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
37
Median 3Y
-8.9
Median 5Y
-11.1
Industry
17.3
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
98
vs Industry
61
Median 3Y
1.4
Median 5Y
1.6
Industry
1.8
More Details

Multiples Across Competitors

MDR Competitors Multiples
Medadvisor Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Medadvisor Ltd
ASX:MDR
48m AUD 0.5 -10.3 -22 -22
US
Veeva Systems Inc
NYSE:VEEV
37.9B USD 13.8 53 44.5 47
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
28.7B AUD 150.3 291.8 204 204
US
Doximity Inc
NYSE:DOCS
9.6B USD 16.9 43.2 36.2 37.9
JP
M3 Inc
TSE:2413
1.3T JPY 4.7 32.7 16.1 19.4
US
Waystar Holding Corp
NASDAQ:WAY
6.7B USD 6.8 256.2 23.2 49.8
SE
Sectra AB
STO:SECT B
60.2B SEK 30.7 101.8 -109.4 -109.4
US
Inspire Medical Systems Inc
NYSE:INSP
4.3B USD 5.3 79.6 89.5 105.7
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
260.4B INR 0 0 0 0
CN
Winning Health Technology Group Co Ltd
SZSE:300253
21.1B CNY 8 275.6 94.6 94.6
P/E Multiple
Earnings Growth PEG
AU
Medadvisor Ltd
ASX:MDR
Average P/E: 131.9
Negative Multiple: -10.3
102%
N/A
US
Veeva Systems Inc
NYSE:VEEV
53
28%
1.9
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
291.8
38%
7.7
US
Doximity Inc
NYSE:DOCS
43.2
11%
3.9
JP
M3 Inc
TSE:2413
32.7
N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
256.2
N/A N/A
SE
Sectra AB
STO:SECT B
101.8
21%
4.8
US
Inspire Medical Systems Inc
NYSE:INSP
79.6
37%
2.2
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
275.6
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Medadvisor Ltd
ASX:MDR
Average EV/EBITDA: 66.3
Negative Multiple: -22
60%
N/A
US
Veeva Systems Inc
NYSE:VEEV
44.5
33%
1.3
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
204
38%
5.4
US
Doximity Inc
NYSE:DOCS
36.2
21%
1.7
JP
M3 Inc
TSE:2413
16.1
13%
1.2
US
W
Waystar Holding Corp
NASDAQ:WAY
23.2
18%
1.3
SE
Sectra AB
STO:SECT B
Negative Multiple: -109.4 N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
89.5
90%
1
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
94.6
48%
2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Medadvisor Ltd
ASX:MDR
Average EV/EBIT: 75.2
Negative Multiple: -22
42%
N/A
US
Veeva Systems Inc
NYSE:VEEV
47
34%
1.4
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
204
36%
5.7
US
Doximity Inc
NYSE:DOCS
37.9
24%
1.6
JP
M3 Inc
TSE:2413
19.4
N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
49.8
44%
1.1
SE
Sectra AB
STO:SECT B
Negative Multiple: -109.4 N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
105.7
65%
1.6
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
94.6
N/A N/A

See Also

Summary
MDR intrinsic value, competitors valuation, and company profile.
DCF Valuation
MDR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MDR stock valuation using valuation multiples.
Wall Street Estimates
MDR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MDR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 257,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.